BioDiscovery develops and sells advanced software solutions and services
that enable its customers to revolutionize drug discovery and diagnostics by
efficiently managing, integrating, and analyzing data generated using
high-throughput microarray and CGH technology. BioDiscovery provides a full line of modular software packages spanning the
entire microarray process, including enterprise data management, image
processing, data mining, statistical analysis, and collaborative knowledge
management.
BioDiscovery was founded in 1997, in Los Angeles, California as a pioneer in
the nascent field of microarray informatics. The company has since positioned
itself as an innovative force in the industry with a strong intellectual
property portfolio encompassing six issued U.S. patents and significant number of
pending applications. This dedicated focus and these continued innovations have produced a
number of first-to-market products and technologies including:
BioDiscovery develops and markets a comprehensive line of
bioinformatics products capable of integrating the entire
microarray experimental process. ImaGene, and
ImaGeneCGH are designed to function as standalone products or
together as integrated software modules. In either mode they
provide novel features and capabilities for automation of array processing, visualization and analysis. With Nexus Copy Number, researchers are able to perform high throughput copy number analysis across all major array platforms.